SHANNON WALLER: Open Payments
NPI 1548802739 · OAKLAND, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$773 in 33 payments from 9 companies in 2025. Trend: 2023 $235 · 2024 $397 · 2025 $773
Food & beverage: $773
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $316 |
| ABBVIE INC. | 7 | $198 |
| Lilly USA, LLC | 3 | $56 |
| Exact Sciences Corporation | 2 | $50 |
| ABIOMED | 1 | $43 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| CARDIVA MEDICAL, INC. | 1 | $24 |
| Alnylam Pharmaceuticals Inc. | 1 | $17 |
Products named: Wegovy, QULIPTA, Cologuard Collection Kit, UBRELVY, ZEPBOUND, Kerendia, BREZTRI, CARDIVA VASCADE MVP VVCS 6-12F.
Industry payments across NJ — which companies pay providers there.
